Ajax-Loading

Johnson & Johnson - Current Deferred Revenue

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Current-Deferred-Revenue" stands at 34.72 Billion United States Dollars as of 09/30/2024, the highest value at least since 03/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1,097.76 percent compared to the value the year prior.
The 1 year change in percent is 1,097.76.
The 3 year change in percent is 226.16.
The 5 year change in percent is 351.18.
The 10 year change in percent is 807.32.

The Serie's long term average value is 4.87 Billion United States Dollars. It's latest available value, on 09/30/2024, is 613.69 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2013, to it's latest available value, on 09/30/2024, is +3,532.11%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 09/30/2024, is 0.0%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11
LogoNovartis AG - Current Deferred Revenue255,096,620,580.91